Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actuate Therapeutics Inc

7.26
+0.01000.14%
Post-market: 7.260.00000.00%16:10 EDT
Volume:58.62K
Turnover:422.21K
Market Cap:142.44M
PE:-3.69
High:7.33
Open:7.25
Low:6.77
Close:7.25
Loading ...
Jul 25, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 15, 2025

Correspondence

Form CORRESP - Correspondence
Mar 28, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans